Abstract: An improved cleaner for paint spray guns in use on an assembly line comprises a vessel having an inlet, a drain and a port for receiving an atomizer of a spray gun. An impeller is rotatably mounted within the vessel in fluid communication with the inlet. The impeller has an offset cleaning nozzle for projecting a cleaning spray towards the port, a rotational nozzle for projecting a rotational spray to effect rotation of the impeller. The impeller also has an independently controlled central nozzle cleaning nozzle. The cleaner has an air wipe down for removing excess solvent from the atomizer of the spray gun as it leaves the cleaner following a wash cycle. The cleaner comprises a helical flushing means and a solvent purge assembly to clean the inner walls of the vessel. An air and solvent separation fitting provides improved solvent drainage efficiency.

Abstract: Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.

Abstract: An improved cleaner for paint spray guns in use on an assembly line comprises a vessel having an inlet, a drain and a port for receiving an atomizer of a spray gun. An impeller is rotatably mounted within the vessel in fluid communication with the inlet. The impeller has an offset cleaning nozzle for projecting a cleaning spray towards the port, a rotational nozzle for projecting a rotational spray to effect rotation of the impeller. The impeller also has an independently controlled central nozzle cleaning nozzle. The cleaner has an air wipe down for removing excess solvent from the atomizer of the spray gun as it leaves the cleaner following a wash cycle. The cleaner comprises a helical flushing means and a solvent purge assembly to clean the inner walls of the vessel. An air and solvent separation fitting provides improved solvent drainage efficiency.

Abstract: Provided are compounds of Formula: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.

Abstract: Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.

Abstract: Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.

Abstract: Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.

Abstract: Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.

Abstract: Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.

Abstract: 4-Benzoylisoxazole derivatives of formula (I), wherein R 1

Abstract: 4-Benzoylisoxazole derivatives of the formula wherein R is H or an ester; R1 is alkyl, haloalkyl or optionally substituted cycloalkyl; R2 is halogen, optionally halogenated alkyl, alkenyl or alkynyl; alkyl substituted with one or more —OR5; —NO2, —CN, —CO2R5, —S(O)pR6, —O(CH2)mOR5, —COR5, —NR5R6, —N(R8)SOqR7, —CONR9R10 or —OR51; or optionally substituted phenyl; R3 is —S(O)qR7; X is —N(R8)—; n is 0, 1, 2, 3, or 4; R5, R51 and R6 are independently H; optionally halogenated alkyl, alkenyl or alkynyl; optionally substituted phenyl; or cycloalkyl; R7 is optionally halogenated alkyl, alkenyl or alkynyl; cycloalkyl; optionally substituted phenyl; or optionally substituted amino; R8 is H; optionally halogenated alkyl, alkenyl or alkynyl; cycloalkyl; optionally substituted phenyl; or alkoxy; m is 1, 2 or 3; p is 0, 1 or 2; q is 0 or 2; and their use as herbicides are described.

Abstract: Herbicides derived from 2-cyano-1,3-diones have the formula: ##STR1## wherein R, R.sup.1, R.sup.2 R.sup.3, R.sup.4 and R.sup.5 are as defined in the description. The compounds are intended for use pre- and post-emergence as selective herbicides in maize and a large number of other monocotyledon crops.

Abstract: Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.